← Back to all trials
Recruiting
NCT07639424
Study to Evaluate a New Cartilage Regeneration Platform for Knee Cartilage Repair
Conditions: Cartilage Defects of the Knee
Sex: All
Ages: 19 Years – 64 Years
Healthy volunteers: No
Phase: PHASE4
Enrollment: 104
Sponsor: ROKIT Healthcare
Location: Catholic University of Korea Bucheon St. Mary's Hospital Bucheon-si Gyeonggi-do
Summary
The goal of this clinical trial is to learn if a new treatment works to help regrow knee cartilage in people with knee cartilage damage. The main questions it aims to answer are:
Does the treatment help the knee work better and lower pain more than the standard surgery?
Is the treatment safe and does it help grow stronger new cartilage?
Researchers will compare participants who get the standard surgery (microfracture) to participants who get both the standard surgery and the new treatment. This is to see if the new treatment leads to a better and faster recovery.
Participants will:
Have a surgery to treat their knee cartilage damage.
Visit the clinic for check-ups to see how well their knee moves.
Take imaging tests, like an MRI, so researchers can look at the new cartilage.
Eligibility Criteria
Inclusion Criteria:
* Adults aged 19 years to \
Source: ClinicalTrials.gov (NCT07639424). StuddyBuddy aggregates publicly available trial information.
